Abstract
This chapter presents the most commonly used serological methods for the diagnosis of Chikungunya virus (CHIKV) infection in humans. CHIKV is a mosquito-borne Alphavirus widely distributed in the tropical and subtropical regions of Africa, Asia, and America. CHIKV infection in human causes acute febrile illness frequently accompanied by severe joint pain. Most of the infected patients may develop chronic arthralgia that may persist for several months or years. Laboratory diagnosis of CHIKV infection is mainly based on molecular and serological tests. The serological tests represent a valuable tool for diagnosis and epidemiological studies. Enzyme-linked immunosorbent assay (ELISA) and immunofluorescence assay (IFA) are simple, rapid, and sensitive techniques widely used for the diagnosis of CHIKV infection. However, these methods represent a screening tool and often require confirmation by a second-line assays. Serum virus neutralization assay is more specific than ELISA and IFA tests and is considered a confirmatory test. Neutralization assay is employed to determine the titer of virus neutralizing antibodies against CHIKV in patients’ sera. The basis of microneutralization assay (MNA), results interpretation, and procedures will be illustrated in this chapter.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Morrison TE (2014) Reemergence of chikungunya virus. J Virol 88:11644–11647
Weaver SC, Lecuit M (2015) Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med 372:1231–1239
Burt FJ, Rolph MS, Rulli NE, Mahalingam S, Heise MT (2012) Chikungunya: a re-emerging virus. Lancet 379:662–671
Schwartz O, Albert ML (2010) Biology and pathogenesis of chikungunya virus. Nat Rev Microbiol 8:491–500
Moro ML, Grilli E, Corvetta A, Silvi G, Angelini R, Mascella F, Miserocchi F, Sambo P, Finarelli AC, Sambri V, Gagliotti C, Massimiliani E, Mattivi A, Pierro AM, Macini P, Study Group “Infezioni da Chikungunya in Emilia-Romagna” (2012) Long-term Chikungunya infection clinical manifestations after an outbreak in Italy: a prognostic cohort study. J Infect 65:165–172
Fact Sheet 327: Chikungunya.” World Health Organization (WHO). Accessed from http://www.who.int/mediacentre/factsheets/fs327/en/
Chusri S, Siripaitoon P, Silpapojakul K, Hortiwakul T, Charernmak B, Chinnawirotpisan P, Nisalak A, Thaisomboonsuk B, Klungthong C, Gibbons RV, Jarman RG (2014) Kinetics of chikungunya infections during an outbreak in Southern Thailand, 2008-2009. Am J Trop Med Hyg 90:410–417
Cavrini F, Gaibani P, Pierro AM, Rossini G, Landini MP, Sambri V (2009) Chikungunya: an emerging and spreading arthropod-borne viral disease. J Infect Dev Ctries 3:744–752
Kucharz EJ, Cebula-Byrska I (2014) Chikungunya fever. Eur J Intern Med 23:325–329
Prat CM, Flusin O, Panella A, Tenebray B, Lanciotti R, Leparc-Goffart I (2014) Evaluation of commercially available serologic diagnostic tests for Chikungunya virus. Emerg Infect Dis 20:2129–2132
Yap G, Pok KY, Lai YL, Hapuarachchi HC, Chow A, Leo YS, Tan LK, Ng LC (2010) Evaluation of Chikungunya diagnostic assays: differences in sensitivity of serology assays in two independent outbreaks. PLoS Negl Trop Dis 4, e753
Pialoux G, Gaüzère BA, Jauréguiberry S, Strobel M (2007) Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 7:319–327
Blacksell SD, Tanganuchitcharnchai A, Jarman RG, Gibbons RV, Paris DH, Bailey MS, Day NP, Premaratna R, Lalloo DG, de Silva HJ (2011) Poor diagnostic accuracy of commercial antibody-based assays for the diagnosis of acute Chikungunya infection. Clin Vaccine Immunol 18:1773–1775
Sambri V, Capobianchi MR, Cavrini F, Charrel R, Donoso-Mantke O, Escadafal C, Franco L, Gaibani P, Gould EA, Niedrig M, Papa A, Pierro A, Rossini G, Sanchini A, Tenorio A, Varani S, Vázquez A, Vocale C, Zeller H (2013) Diagnosis of west nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studies. Viruses 5:2329–2348
Reed LJ, Muench H (1983) A simple method of estimating fifty percent endpoints. Am J Hygiene 27:493–497
Doyle A, Griffiths JB, Newell DG (1995) Cell and tissue culture: laboratory procedures. John Wiley, Chichester
WHO (2007) Guidelines for plaque reduction neutralization testing of human antibodies to dengue virus. Accessed from http://whqlibdoc.who.int/hq/2007/who_ivb_07.07_eng.pdf
Hierholzer JC, Bingham PG (1978) Vero microcultures for adenovirus neutralization tests. J Clin Microbiol 7:499–506
Greig AS (1969) A serum neutralization test for infectious bovine rhinotracheitis based on colour reaction and cytopathic effects in cell culture. Can J Comp Med 33:85–88
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Gaibani, P., Landini, M.P., Sambri, V. (2016). Diagnostic Methods for CHIKV Based on Serological Tools. In: Chu, J., Ang, S. (eds) Chikungunya Virus. Methods in Molecular Biology, vol 1426. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3618-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3618-2_6
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3616-8
Online ISBN: 978-1-4939-3618-2
eBook Packages: Springer Protocols